Staar Surgical Co (STAA)

$41.42

-0.45

(-1.07%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $40.79
    $42.47
    $41.42
    downward going graph

    1.53%

    Downside

    Day's Volatility :3.96%

    Upside

    2.46%

    downward going graph
  • $26.66
    $58.35
    $41.42
    downward going graph

    35.63%

    Downside

    52 Weeks Volatility :54.31%

    Upside

    29.01%

    downward going graph

Returns

PeriodStaar Surgical CoSector (Health Care)Index (Russel 2000)
3 Months
-12.44%
5.5%
0.0%
6 Months
39.57%
7.2%
0.0%
1 Year
-27.46%
9.3%
0.0%
3 Years
-66.82%
13.0%
-19.9%

Highlights

Market Capitalization
2.1B
Book Value
$8.0
Earnings Per Share (EPS)
0.31
PE Ratio
138.35
PEG Ratio
-4.89
Wall Street Target Price
50.59
Profit Margin
4.69%
Operating Margin TTM
-2.87%
Return On Assets TTM
3.38%
Return On Equity TTM
4.18%
Revenue TTM
326.2M
Revenue Per Share TTM
6.7
Quarterly Revenue Growth YOY
5.2%
Gross Profit TTM
223.4M
EBITDA
29.9M
Diluted Eps TTM
0.31
Quarterly Earnings Growth YOY
0.22
EPS Estimate Current Year
0.61
EPS Estimate Next Year
0.83
EPS Estimate Current Quarter
0.04
EPS Estimate Next Quarter
0.24

Analyst Recommendation

Buy
    63%Buy
    36%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Staar Surgical Co(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
11
9
Hold
7
8
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 22.14%

Current $41.42
Target $50.59

Technicals Summary

Sell

Neutral

Buy

Staar Surgical Co is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Staar Surgical Co
Staar Surgical Co
1.75%
39.57%
-27.46%
-66.82%
28.16%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
6.06%
22.97%
40.64%
41.31%
151.4%
Resmed Inc.
Resmed Inc.
15.0%
21.98%
-3.96%
-19.33%
67.01%
Becton, Dickinson And Company
Becton, Dickinson And Company
-0.67%
-0.1%
-16.3%
-6.05%
-8.55%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
-4.48%
-9.33%
-15.92%
-16.25%
158.59%
Alcon Ag
Alcon Ag
1.12%
18.8%
8.85%
29.4%
54.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Staar Surgical Co
Staar Surgical Co
138.35
138.35
-4.89
0.61
0.04
0.03
NA
8.0
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
79.37
79.37
7.13
6.56
0.16
0.08
NA
41.4
Resmed Inc.
Resmed Inc.
31.84
31.84
1.75
7.73
0.22
0.12
0.01
31.52
Becton, Dickinson And Company
Becton, Dickinson And Company
49.48
49.48
1.34
13.04
0.05
0.03
0.02
88.74
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
42.01
42.01
6.72
7.74
0.21
0.11
0.0
36.72
Alcon Ag
Alcon Ag
42.94
42.94
4.59
3.07
0.05
0.02
0.0
42.13
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Staar Surgical Co
Staar Surgical Co
Buy
$2.1B
28.16%
138.35
4.69%
Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
Buy
$163.9B
151.4%
79.37
27.65%
Resmed Inc.
Resmed Inc.
Buy
$30.5B
67.01%
31.84
20.91%
Becton, Dickinson And Company
Becton, Dickinson And Company
Buy
$66.8B
-8.55%
49.48
6.76%
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
Buy
$23.3B
158.59%
42.01
19.42%
Alcon Ag
Alcon Ag
Buy
$44.7B
54.04%
42.94
10.96%

Insights on Staar Surgical Co

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 76.27M → 77.35M (in $), with an average increase of 0.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 7.75M → -3.33M (in $), with an average decrease of 71.5% per quarter

  • Vs ISRG

    In the last 1 year, Intuitive Surgical, Inc. has given 40.6% return, outperforming this stock by 68.1%

  • Vs ISRG

    In the last 3 years, Intuitive Surgical, Inc. has given 39.8% return, outperforming this stock by 108.1%

Institutional Holdings

  • BROADWOOD CAPITAL Inc

    21.92%
  • BlackRock Inc

    15.72%
  • Vanguard Group Inc

    11.15%
  • Baillie Gifford & Co Limited.

    8.38%
  • State Street Corporation

    3.94%
  • Palo Alto Investors, LLC

    2.81%

Company Information

staar surgical company (nasdaq: staa), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. the company offers the evo visian implantable collamer® lenses (icls) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and hyperopic icl, which treats far-sightedness. these lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. all of these lenses are foldable, which permits the surgeon to insert them through a small incision. staar's lens used in refractive surgery is called an implantable collamer lens or "icl"​. nearly 600,000 visian icls have been implanted to date. it also provides minimally invasive intraocular lenses (iols), including foldable iols for use in minimally invasive cataract surgical procedures; aspheric iols that produce a clearer image than trad

Organization
Staar Surgical Co
Employees
1056
CEO
Mr. Thomas G. Frinzi
Industry
Health Technology

FAQs